A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis

Archives of Otolaryngology - Head and Neck Surgery

Volumn 132, Issue 2, 2006, Pages 179-185

  Stjärne, Pär ^a   Mösges, Ralph ^b   Jorissen, Mark ^c   Passàli, Desiderio ^d   Bellussi, Luisa ^d   Staudinger, Heribert ^e   Danzig, Melvyn ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF SIENA   (Italy)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOMETASONE FUROATE; PLACEBO;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NOSE CONGESTION; NOSE POLYP; PATIENT ASSESSMENT; PHYSICIAN; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF EVALUATION; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; PREGNADIENEDIOLS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33644830018     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.132.2.179     Document Type: Article

References (29)

1. Larsen PL, Tingsgaard PK, Harcourt J, Sofsrud G, Tos M. Nasal polyps and their relation to polyps/hypertrophic polypoid mucosa in the paranasal sinuses: a macro-, endo-, and microscopic study of autopsy materials. Am J Rhinol. 1998;12:45-51.
2. Coste A, Rateau JG, Roudot-Thoraval F, et al. Increased epithelial cell proliferation in nasal polyps. Arch Otolaryngol Head Neck Surg. 1996;122:432-436.
3. Settipane GA. Epidemiology of nasal polyps. In: Nasal Polyps: Epidemiology, Pathogenesis and Treatment. Providence, RI: OceanSide Publications Inc; 1997:17-24.
4. Blomqvist EH, Lundblad L, Anggard A, Haraldsson PO, Stjarne P. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol. 2001;107:224-228.
5. Bachert C, Hormann K, Mosges R, et al. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy. 2003;58:176-191.
6. Hellquist HB. Nasal polyps update: histopathology. Allergy Asthma Proc. 1996;17:237-242.
7. Mygind N. Advances in the medical treatment of nasal polyps. Allergy. 1999;54(suppl 53):12-16.
8. Badia L, Lund V. Topical corticosteroids in nasal polyposis. Drugs. 2001;61:573-578.
9. Burgel PR, Cardell LO, Ueki IF, Nadel JA. Intranasal steroids decrease eosinophils but not mucin expression in nasal polyps. Eur Respir J. 2004;24:594-600.
10. Bachert C, Wagenmann M, Hauser U, Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol. 1997;99:837-842.
11. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol. 1997;158:3902-3908.
12. Saunders MW, Wheatley AH, George SJ, Lai T, Birchall MA. Do corticosteroids induce apoptosis in nasal polyp inflammatory cells? In vivo and in vitro studies. Laryngoscope. 1999;109:785-790.
13. Mygind N, Pedersen CB, Prytz S, Sorensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy. 1975;5:159-164.
14. Deuschl H, Drettner B. Nasal polyps treated by beclomethasone nasal aerosol. Rhinology. 1977;15:17-23.
15. Chalton R, Mackay I, Wilson R, Cole P. Double-blind, placebo-controlled trial of beclomethasone nasal drops for nasal polyposis. Br Med J (Clin Res Ed). 1985;291:788.
16. Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol Allied Sci. 1995;20:26-30.
17. Vendelo Johansen L, Illum P, Kristensen S, Winther L, Vang Petersen S, Synnerstad B. The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol Allied Sci. 1993;18:524-527.
18. Ruhno J, Andersson B, Denburg J, et al. A double-blind comparison of intranasal budesonide with placebo for nasal polyposis. J Allergy Clin Immunol. 1990;86:946-953.
19. Holmberg K, Juliusson S, Balder B, Smith DL, Richards DH, Karlsson G. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol. 1997;78:270-276.
20. Lund VJ, Flood J, Sykes AP, Richards DH. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg. 1998;124:513-518.
21. Jankowski R, Schrewelius C, Bonfils P, et al. Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch Otolaryngol Head Neck Surg. 2001;127:447-452.
22. Filiaci F, Passali D, Puxeddu R, Schrewelius C. A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis. Rhinology. 2000;38:185-190.
23. Berkowitz RB, Roberson S, Zora J, et al. Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting. Allergy Asthma Proc. 1999;20:167-172.
24. Bronsky EA, Aaronson DW, Berkowitz RB, et al. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1997;79:51-56.
25. Davies RJ, Nelson HS. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin Ther. 1997;19:27-38.
26. Graft D, Aaronson D, Chervinsky P, et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol. 1996;98:724-731.
27. Schenkel E. Features of mometasone furoate nasal spray and its utility in the management of allergic rhinitis. Expert Opin Pharmacother. 2003;4:1579-1591.
28. Brannan MD, Seiberling M, Cutler MD, et al. Lack of systemic activity with intranasal mometasone furoate. J Allergy Clin Immunol. 1996;97:198.
29. Mehle ME. Are nasal steroids safe? Curr Opin Otolaryngol Head Neck Surg. 2003;11:201-205.